{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:59:50Z","timestamp":1785895190179,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"ALF"},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation Samariten"},{"name":"Sachs\u2019 Children and Youth Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.031","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T03:35:56Z","timestamp":1469676956000},"page":"4565-4571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden"],"prefix":"10.1016","volume":"34","author":[{"given":"Ann","family":"Lindstrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Galanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Darenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Naucler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alfv\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Henriques-Normark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"\u00d6rtqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.031_b0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/142.6.923","article-title":"Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life","volume":"142","author":"Gray","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.vaccine.2013.06.040","article-title":"Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27\u201328, 2012, Geneva","volume":"32","author":"Goldblatt","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/aje\/kwt156","article-title":"Using pneumococcal carriage data to monitor postvaccination changes in invasive disease","volume":"178","author":"Weinberger","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.07.031_b0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/infdis\/jir730","article-title":"Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities","volume":"205","author":"Scott","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0030","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.07.031_b0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sjostrom","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jit481","article-title":"Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children","volume":"209","author":"Browall","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0055","unstructured":"IVAC. VIMS Global Vaccine introduction, December 2015."},{"key":"10.1016\/j.vaccine.2016.07.031_b0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","article-title":"The worldwide impact of the seven-valent pneumococcal conjugate vaccine","volume":"31","author":"Fitzwater","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.031_b0065","doi-asserted-by":"crossref","first-page":"e1528","DOI":"10.1542\/peds.2013-4177","article-title":"Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine","volume":"134","author":"Lindstrand","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.07.031_b0070","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.vaccine.2015.08.022","article-title":"Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom","volume":"33","author":"Lau","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0075","first-page":"CD004977","article-title":"Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age","author":"Lucero","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.07.031_b0080","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0085","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.031_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-200101000-00006","article-title":"Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine","volume":"20","author":"Nurkka","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.031_b0095","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2009.12.054","article-title":"Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule","volume":"28","author":"Vestrheim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0105","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2007.04.088","article-title":"Herd immunity and pneumococcal conjugate vaccine: a quantitative model","volume":"25","author":"Haber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0110","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.vaccine.2013.03.024","article-title":"Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination","volume":"31","author":"Dunne","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0115","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2016.07.031_b0120","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S095026881200218X","article-title":"Laboratory surveillance of invasive pneumococcal disease in New South Wales, Australia, before and after introduction of 7-valent conjugate vaccine: reduced disease, but not antibiotic resistance rates","volume":"141","author":"Oftadeh","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.07.031_b0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.vaccine.2015.01.003","article-title":"Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli collaborative research (PICR)","volume":"33","author":"Daana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0130","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2013.07.054","article-title":"Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations","volume":"31","author":"Hackel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0135","unstructured":"The Swedish national vaccination program - year report 2014. Stockholm, Sweden: The Public Health Agency of Sweden; 2015."},{"key":"10.1016\/j.vaccine.2016.07.031_b0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Res J"},{"key":"10.1016\/j.vaccine.2016.07.031_b0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/107662903322762761","article-title":"Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers","volume":"9","author":"Henriques Normark","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2016.07.031_b0150","first-page":"13","article-title":"Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing","volume":"105","author":"Olsson-Liljequist","year":"1997","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.vaccine.2016.07.031_b0155","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/JCM.39.11.4190-4192.2001","article-title":"Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms","volume":"39","author":"Grundmann","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.07.031_b0160","unstructured":"Child Health Clinics in Stockholm County \u2013 yearly report 2014. Stockholm Central Child Health; 2014."},{"key":"10.1016\/j.vaccine.2016.07.031_b0165","doi-asserted-by":"crossref","first-page":"e1004173","DOI":"10.1371\/journal.pcbi.1004173","article-title":"The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease","volume":"11","author":"Flasche","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2016.07.031_b0170","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.07.031_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-12-207","article-title":"Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective","volume":"12","author":"Weil-Olivier","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands","volume":"34","author":"Bosch","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0185","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0190","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.vaccine.2013.04.075","article-title":"Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysis","volume":"31","author":"Tocheva","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0195","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.vaccine.2012.03.058","article-title":"Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity","volume":"30","author":"Rodrigues","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0200","first-page":"1","article-title":"Changes in pneumococcal serotypes and antibiotypes carries by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine","volume":"10","author":"S\u00e1-Le\u00e3o","year":"2009","journal-title":"Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/17476348.2013.816572","article-title":"Advances in pneumococcal antibiotic resistance","volume":"7","author":"Song","year":"2013","journal-title":"Expert Rev Res Med"},{"key":"10.1016\/j.vaccine.2016.07.031_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3947\/ic.2013.45.1.76","article-title":"Nasopharyngeal carriage rate and serotypes of Streptococcus pneumoniae and antimicrobial susceptibility in healthy Korean children younger than 5 years old: focus on influence of pneumococcal conjugate vaccination","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemoth"},{"key":"10.1016\/j.vaccine.2016.07.031_b0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmi.2014.08.009","article-title":"Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001\u20132011 survey by the French Pneumococcal Network","volume":"21","author":"Kempf","year":"2015","journal-title":"Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0220","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jiu576","article-title":"Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae","volume":"211","author":"Dagan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/00365548.2012.734919","article-title":"Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers","volume":"45","author":"Skovbjerg","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.031_b0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.031_b0235","doi-asserted-by":"crossref","first-page":"e1001903","DOI":"10.1371\/journal.pmed.1001903","article-title":"The PneuCarriage project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies","volume":"12","author":"Satzke","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.07.031_b0240","doi-asserted-by":"crossref","first-page":"e76309","DOI":"10.1371\/journal.pone.0076309","article-title":"Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy","volume":"8","author":"Camilli","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.031_b0245","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1128\/JCM.01913-06","article-title":"Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci","volume":"45","author":"Hogberg","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.07.031_b0250","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1183\/09031936.00080814","article-title":"Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types","volume":"44","author":"Browall","year":"2014","journal-title":"Eur Res J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T06:22:38Z","timestamp":1536560558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":50,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306144"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}